Relmada Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
RLMD on Nasdaq
Industry
Pharmaceutical Preparations
Location
2222 Ponce De Leon Blvd. 3 Rd Floor, Coral Gables, FL

Insiders trading volume in the past year

Relmada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sergio Traversa Chief Executive Officer, Director $1.15M +$782K +213% Sep 9, 2024
Paul Kelly Director $550K +$64.8K +13.3% Sep 9, 2024
Maged Shenouda Chief Financial Officer $261K +$275K Sep 9, 2024
Chuck Ence CA and CO $158K +$151K +2127% May 24, 2024
Charles J. Casamento Director $33.3K +$33.3K Sep 9, 2024
Cedric O'Gorman Chief Medical Officer $32.2K May 23, 2023
John Glasspool Director May 24, 2024
Fabiana Fedeli Director May 24, 2024
Eric Schmidt Director May 25, 2023

Recent Insider Transactions by Companies or Individuals for Relmada Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.